<div id="readability-page-1">02:02 PM EDT, 05/19/2026 (MT Newswires) -- Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State Street Healthcare Select Sector SPDR ETF (XLV) gaining 1.2%.The iShares Biotechnology ETF (IBB) increased 0.5%.In sector news, Nourish, a nutrition counseling startup focused on supporting patients using GLP-1 weight-loss drugs, raised $100 million in a Series C funding round led by Menlo Ventures, the company said Tuesday. The round included participation from Thrive Capital, Index Ventures, JPMorgan Chase's (JPM) growth equity arm, Maverick Ventures, Y Combinator and others, the company said.In corporate news, Boston Scientific ( BSX ) shares gained 1.4% after the company said Tuesday that a trial evaluating its investigational catheter for treating severe coronary artery disease met primary safety and effectiveness endpoints.Relay Therapeutics ( RLAY ) shares climbed 5.2% after it said early phase 2 data showed its experimental drug zovegalisib reduced lesion volume in patients with rare vascular anomalies linked to PIK3CA mutations.Tiziana Life Sciences' ( TLSA ) intranasal foralumab showed good long-term tolerability and fatigue improvement in an expanded access program involving 14 patients with non-active secondary progressive multiple sclerosis based on updated clinical data, the company said. Its shares rose 3.7%.MetaVia ( MTVA ) shares were up 58% in Tuesday trading, a day after the company said three late-breaking abstracts highlighting its cardiometabolic assets were accepted for poster presentations at the American Diabetes Association's 2026 Scientific Sessions. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

TLSA

MTVA

LABU

Healthcare stocks rose on Tuesday, with the NYSE Healthcare Index up 1.1% and the State Street Healthcare Select Sector SPDR ETF gaining 1.2%. Nourish raised $100 million in Series C funding. Boston Scientific shares increased 1.4% after positive trial results, while Relay Therapeutics saw a 5.2% rise following promising drug data. Tiziana Life Sciences' shares rose 3.7% based on favorable clinical data. MetaVia's shares surged 58% after three abstracts were accepted for presentation at the American Diabetes Association's 2026 Scientific Sessions.

Fidelity

Tiziana Life Sciences

Boston Scientific

MetaVia

Direxion S&P Biotech Bull 3X

VG Health

Health Care Select Sector SPDR

iShares Biotechnology ETF

JPMorgan Chase

Relay Therapeutics

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Sector Update: Healthcare Stocks Rise Tuesday Afternoon